(Q33330147)
Statements
A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation (English)
Rinaldi DA
Kuhn JG
Burris HA
Dorr FA
Rodriguez G
Eckhardt SG
Jones S
Woodworth JR
Langley C
Mascorro D
Abrahams T